$0.5832
-0.03-4.33%
At close: -
$0.5800
-0.00320-0.55%
After Hours: 6:42 PM EDT
Comments
Loading...
Cognition Therapeutics (CGTX) Forecast
NewsEarningsCognition Therapeutics (CGTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCognition Therapeutics (NASDAQ:CGTX) Stock Quotes, Forecast and News Summary
Cognition Therapeutics Stock (NASDAQ: CGTX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cognition Therapeutics (CGTX) stock?
You can purchase shares of Cognition Therapeutics (NASDAQ:CGTX) through any online brokerage.
Who are Cognition Therapeutics (CGTX) competitors?
Other companies in Cognition Therapeutics’s space includes: Iterum Therapeutics (NASDAQ:ITRM), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX) and CalciMedica (NASDAQ:CALC).
What is the forecast, or price target, for Cognition Therapeutics (CGTX) stock?
Cognition Therapeutics has a consensus price target of $7.92.
What is the current price for Cognition Therapeutics (CGTX)?
The stock price for Cognition Therapeutics (NASDAQ: CGTX) is $0.58 last updated February 21, 2025 at 6:42 PM EST.
Does Cognition Therapeutics (CGTX) pay a dividend?
There are no upcoming dividends for Cognition Therapeutics.
When is Cognition Therapeutics (NASDAQ:CGTX) reporting earnings?
Cognition Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Cognition Therapeutics (CGTX) going to split?
There is no upcoming split for Cognition Therapeutics.
What sector and industry does Cognition Therapeutics (CGTX) operate in?
Cognition Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.